Strikingly, there were no significant differences in the frequencies of any of the myelin-specific CD8+ T cell populations in MS patients in comparison to HLA allele-matched healthy controls (Fig. 2 B and C). The gene discussed is CD8A; the disease is myeloid sarcoma.